Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Hexter Joshua sold 137,000 Oramed Pharmaceuticals Inc. shares (Form 4)
Traded Jul 1 to Jul 2, 2026 · Filed Jul 2, 2026
From Jul 1 to Jul 2, 2026, Hexter Joshua (COO & CBO) sold 137,000 Oramed Pharmaceuticals Inc. shares at US$4.46 for US$611K, leaving 1,073,384 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 137,000 shares
- Price
- US$4.46
- Value
- US$611K
- Holding after
- 1,073,384 shares
- Trading plan
- No
- Role
- COO & CBO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Sale | 137,000 | US$4.46 | 1,023,384 | Direct |
| Jul 2, 2026 | Common Stock | Option exercise | 50,000 | US$3.69 | 1,073,384 | Direct |
Source
Related
- Oramed Pharmaceuticals Inc.
- Hexter Joshua
- Oramed Pharmaceuticals Inc. shareholders
- Form 4 · Hexter Joshua · Oct 2, 2026
- Form 4 · Hexter Joshua · Sep 25, 2026
- Form 4 · Gabay Avraham · Oct 2, 2026
- Form 4 · Kidron Nadav · Sep 25, 2026
- Form 4 · Kidron Miriam · Sep 25, 2026
- Form 4 · Gabay Avraham · Sep 25, 2026
- Schedule 13G/A · Aquamarine Financial (Cayman) Ltd · Aug 14, 2026